Efficacy of high-flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failure

Transfusion and Apheresis Science

Volumn 40, Issue 1, 2009, Pages 61-70

  Yokoi, Takehito ^a,b   Oda, Shigeto ^a   Shiga, Hidetoshi ^b   Matsuda, Ken ichi ^c   Sadahiro, Tomohito ^a   Nakamura, Masataka ^a   Hirasawa, Hiroyuki ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Artificial liver support; Fulminant hepatic failure; Hepatic encephalopathy; High flow dialysate continuous hemodiafiltration; Plasma exchange; Slow plasma exchange plus continuous hemodiafiltration

Indexed keywords

ADULT; ARTICLE; BLOOD; COMA; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; FEMALE; HUMAN; LIVER FAILURE; LIVER SUPPORT; MAJOR CLINICAL STUDY; MALE;

ADULT; COMA; DISEASE-FREE SURVIVAL; FEMALE; HEMODIAFILTRATION; HUMANS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 59649108753     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2008.11.006     Document Type: Article

References (27)

1. Trey C., Lipworth L., Chalmers T.C., Davidson C.S., Gottlieb L.S., Popper H., et al. Fulminant hepatic failure. Presumable contribution to halothane. N Engl J Med 279 (1968) 798-801
2. Mas A., and Rodes J. Fulminant hepatic failure. Lancet 349 (1997) 1081-1085
3. Fujiwara K., Mochida S., Matsui A., Nakayama N., Nagoshi S., and Toda G. Fulminant hepatitis and late onset hepatic failure in Japan. Hepatology Res 38 (2008) 646-657
4. The Proceedings of the 12th Inuyama Symposium. Hepatitis Type A and Fulminant Hepatitis. Tokyo: Chugai Igaku-sya; 1982 (in Japanese).
5. Mochida S., and Fujiwara K. Symposium on clinical aspects in hepatitis virus infection. Recent advances in acute and fulminant hepatitis in Japan. Intern Med 40 (2001) 175-177
6. Nitta M., Hirasawa H., Oda S., Shiga H., Nakanishi K., Matsuda K., et al. Long-term survivors with liver support in fulminant hepatic failure. Ther Apher 6 (2002) 208-212
7. Gill R.Q., and Sterling R.K. Acute liver failure. J Clin Gastroenterol 33 (2001) 191-198
8. Sadahiro T., Hirasawa H., Oda S., Shiga H., Nakanishi K., Kitamura N., et al. Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure. Crit Care Med 29 (2001) 1386-1392
9. Nakanishi K., Hirasawa H., Oda S., Shiga H., Matsuda K., Nakamura M., et al. Intracranial pressure monitoring in patients with fulminant hepatic failure treated with plasma exchange and continuous hemodiafiltration. Blood Purif 23 (2005) 113-118
10. Detry O., Roover A., Honore P., and Meurisse M. Brain edema and intracranial hypertension in fulminant hepatic failure. Pathophysiology and management. World J Gastroenterol 12 (2006) 7405-7412
11. Hirasawa H., Sugai T., Oda S., Shiga H., Matsuda K., Ueno H., et al. Efficacy and limitation of apheresis therapy in critical care. Ther Apher 1 (1997) 228-232
12. Stadlbauer V., and Jalan R. Acute liver failure: liver support therapies. Current Opin Crit Care 13 (2007) 215-221
13. Watanabe A., Hayashi S., and Higashi T. Characteristic change in serum amino acid levels in different type of hepatic encephalopathy. Gastroenterol Jpn 17 (1982) 218-223
14. Odeh M. Pathogenesis of hepatic encephalopathy: the tumor necrosis factor-alpha theory. Eur J Clin Invest 37 (2007) 291-304
15. Norenberg M.D., Rao K.V., and Jayakumar A.R. Mechanisms of ammonia-induced astrocyte swelling. Metab-Brain Dis 20 (2005) 303-318
16. Liu JP, Gluud LL, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for liver failure. The cochrane database of systematic reviews. Art No.CD 003628; 2004.
17. Kjaergard L.L., Liu J., and Als-Nielsen B. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 289 (2003) 217-222
18. Heemann U., Treichel U., Loock J., Philipp T., Gerken G., Malago M., et al. Albumin dialysis in cirrhosis with superimposed acute liver injury. A prospective, controlled study. Hepatology 36 (2002) 949-958
19. Rifai K., Ernst T., Kretschmer U., Bahr M.J., Schneider A., Hafer C., et al. Prometheus; a new extracorporeal system for the treatment of liver failure. J Hepatol 39 (2003) 984-990
20. Barshes N.R., Gay A.N., Williams B., Patel A.J., and Awad S.S. Support for the acutely failing liver. A comprehensive review of historic and contemporary strategies. J Am Coll Surg 201 (2005) 458-476
21. Millis J.M., and Losanoff J.E. Technology insight: liver support systems. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 398-405
22. Wai C.T., Lim S.G., Aung M.O., Lee Y.M., Sutedja D.S., Dan Y.Y., et al. MARS: a futile tool in centres without active liver transplant support. Liver Int 27 (2007) 69-75
23. Sen S., Jalan R., and Williams R. Extracorporeal albumin dialysis in acute-on-chronic liver failure. Will it stand the test of time?. Hepatology 36 (2002) 1014-1016
24. Kamath P.S. Is there life in MARS?. Hepatology 36 (2002) 1017-1019
25. Demetriou A.A., Brown Jr. R.S., Busuttil R.W., Fair J., McGuire B.M., Rosenthal P., et al. Prospective, randomized, multicenter, controlled trial of bioartificial liver in treating acute liver failure. Ann Surg 239 (2004) 660-670
26. Rozga J., Umehara Y., Trofimenko A., Sadahiro T., and Demetriou A.A. A novel plasma filtration therapy for hepatic failure: preclinical studies. Ther Apher Dial 10 (2006) 138-144
27. O'Grady J.G., Alexander G.J., Thick M., Potter D., Calne R.Y., and Williams R. Outcome of orthotopic liver transplantation in the aetiological and clinical variants of acute liver failure. Q J Med 69 (1988) 817-824